Therapeutic challenges and emerging strategies against carbapenem-resistant Acinetobacter baumannii

Carbapenem-resistant Acinetobacter baumannii (CRAB) remains a formidable clinical challenge, driven by limited therapeutic options and multifaceted resistance mechanisms. While current polypharmacy regimens require evidence-based refinement, several emerging antimicrobials offer renewed hope. Sulbac...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chunhong Yang, Jing Li, Xiao Luo, Zhangyong Song, Jinping Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-01-01
coleção:	Current Research in Microbial Sciences
Assuntos:	Carbapenem-resistant Acinetobacter baumannii Antimicrobial therapy Sulbactam-durlobactam Cefiderocol Novel therapeutic strategies
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666517426000362
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!